Bicara Therapeutics Inc. (BCAX) vs Immatics N.V. (IMTX)

Bicara Therapeutics Inc. and Immatics N.V. are both Biotechnology companies. Bicara Therapeutics Inc. and Immatics N.V. are of similar size ($1.3B and $1.3B). Bicara Therapeutics Inc. has the higher net margin (0.00% vs −489.4%) and the higher return on invested capital (0.00% vs −84.8%). Across the 12 metrics below, Bicara Therapeutics Inc. leads on 10 and Immatics N.V. on 2.

Valuation

Metric BCAX IMTX Biotechnology median
P/E n/m n/m 7.88
P/S n/m 23.25 11.47
P/B 2.78 2.46 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 17.76 10.73
Earnings yield (16.14%) (22.22%) (28.84%)
Free cash flow yield (10.36%) (21.01%) (23.03%)

Profitability

Metric BCAX IMTX Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (536.26%) 0.00%
Net margin 0.00% (489.35%) 0.00%
Free cash flow margin 0.00% (488.01%) 0.00%
Return on equity (41.01%) (48.53%) (57.72%)
Return on assets (38.38%) (39.83%) (49.22%)
Return on invested capital 0.00% (84.83%) 0.00%

Growth

Metric BCAX IMTX Biotechnology median
Revenue growth (TTM) — (64.99%) 5.64%
EPS growth (last fiscal year) 37.78% (1,313.33%) —
Revenue growth, 5-year CAGR — 11.81% 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BCAX IMTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.59 7.54 4.73
Net debt to EBITDA 2.67 2.04 0.96

Dividend

Metric BCAX IMTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric BCAX IMTX Biotechnology median
Market cap 1.32b 1.26b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack